From research to innovation
Transforming scientific advances made by researchers into therapeutic and diagnostic innovations is a core mission of Imagine. Today, the Institute contributes to the development of more than 100 solutions originating from its laboratories’ research activities, a quarter of which involve at least one industrial partner. Around 300 additional solutions, developed outside the Institute’s laboratories, are being tested clinically within the clinical units and reference centers for rare diseases that form Imagine’s clinical scope, often in response to the needs of industrial partners.
Imagine’s translational research capabilities—unique worldwide in the field of genetic diseases—thus support a portfolio of over 400 solutions at various stages of development, ranging from preclinical research to phase 3 clinical trials.
A single point of contact for all administrative formalities
The Innovation and Technology Transfer Department supports researchers in carrying out their biomedical innovation projects, establishing R&D partnerships with industry, and creating start-ups dedicated to future developments. Working closely with all stakeholders and private partners—industrial companies, entrepreneurs and investors—the Department facilitates all necessary procedures, particularly regulatory and contractual aspects, identification of partners and external funding, and intellectual property management. Imagine also benefits from an ecosystem particularly conducive to the development of biomedical innovations.
Innovativaton acceleration programs
Imagine has established several initiatives to launch and accelerate high-potential innovation projects. These three programs aim to help projects and their leaders mature through dedicated valorization support mechanisms:
- Innogrant
- Springboard to accelerate projects intended for the creation of a start-up,
- Bioentrepreneurs to train entrepreneurs alongside researchers.